| pubmed-article:17265480 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17265480 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:17265480 | lifeskim:mentions | umls-concept:C0003873 | lld:lifeskim |
| pubmed-article:17265480 | lifeskim:mentions | umls-concept:C0332307 | lld:lifeskim |
| pubmed-article:17265480 | lifeskim:mentions | umls-concept:C0597357 | lld:lifeskim |
| pubmed-article:17265480 | lifeskim:mentions | umls-concept:C0017431 | lld:lifeskim |
| pubmed-article:17265480 | lifeskim:mentions | umls-concept:C2612728 | lld:lifeskim |
| pubmed-article:17265480 | lifeskim:mentions | umls-concept:C0450442 | lld:lifeskim |
| pubmed-article:17265480 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:17265480 | pubmed:dateCreated | 2007-2-22 | lld:pubmed |
| pubmed-article:17265480 | pubmed:abstractText | To determine whether a functional single-nucleotide polymorphism in the gene encoding Fcgamma receptor type IIIA (FcgammaRIIIA) correlates with the response to treatment with tumor necrosis factor alpha inhibitors in rheumatoid arthritis (RA). | lld:pubmed |
| pubmed-article:17265480 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17265480 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17265480 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:17265480 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17265480 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17265480 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17265480 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17265480 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17265480 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17265480 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17265480 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17265480 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17265480 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17265480 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:17265480 | pubmed:issn | 0004-3591 | lld:pubmed |
| pubmed-article:17265480 | pubmed:author | pubmed-author:SkoghThomasT | lld:pubmed |
| pubmed-article:17265480 | pubmed:author | pubmed-author:LampaJonJ | lld:pubmed |
| pubmed-article:17265480 | pubmed:author | pubmed-author:SöderkvistPet... | lld:pubmed |
| pubmed-article:17265480 | pubmed:author | pubmed-author:BrattJohanJ | lld:pubmed |
| pubmed-article:17265480 | pubmed:author | pubmed-author:PadyukovLeoni... | lld:pubmed |
| pubmed-article:17265480 | pubmed:author | pubmed-author:ErnestamSofia... | lld:pubmed |
| pubmed-article:17265480 | pubmed:author | pubmed-author:KastbomAlfA | lld:pubmed |
| pubmed-article:17265480 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17265480 | pubmed:volume | 56 | lld:pubmed |
| pubmed-article:17265480 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17265480 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17265480 | pubmed:pagination | 448-52 | lld:pubmed |
| pubmed-article:17265480 | pubmed:meshHeading | pubmed-meshheading:17265480... | lld:pubmed |
| pubmed-article:17265480 | pubmed:meshHeading | pubmed-meshheading:17265480... | lld:pubmed |
| pubmed-article:17265480 | pubmed:meshHeading | pubmed-meshheading:17265480... | lld:pubmed |
| pubmed-article:17265480 | pubmed:meshHeading | pubmed-meshheading:17265480... | lld:pubmed |
| pubmed-article:17265480 | pubmed:meshHeading | pubmed-meshheading:17265480... | lld:pubmed |
| pubmed-article:17265480 | pubmed:meshHeading | pubmed-meshheading:17265480... | lld:pubmed |
| pubmed-article:17265480 | pubmed:meshHeading | pubmed-meshheading:17265480... | lld:pubmed |
| pubmed-article:17265480 | pubmed:meshHeading | pubmed-meshheading:17265480... | lld:pubmed |
| pubmed-article:17265480 | pubmed:meshHeading | pubmed-meshheading:17265480... | lld:pubmed |
| pubmed-article:17265480 | pubmed:meshHeading | pubmed-meshheading:17265480... | lld:pubmed |
| pubmed-article:17265480 | pubmed:meshHeading | pubmed-meshheading:17265480... | lld:pubmed |
| pubmed-article:17265480 | pubmed:meshHeading | pubmed-meshheading:17265480... | lld:pubmed |
| pubmed-article:17265480 | pubmed:meshHeading | pubmed-meshheading:17265480... | lld:pubmed |
| pubmed-article:17265480 | pubmed:meshHeading | pubmed-meshheading:17265480... | lld:pubmed |
| pubmed-article:17265480 | pubmed:meshHeading | pubmed-meshheading:17265480... | lld:pubmed |
| pubmed-article:17265480 | pubmed:meshHeading | pubmed-meshheading:17265480... | lld:pubmed |
| pubmed-article:17265480 | pubmed:meshHeading | pubmed-meshheading:17265480... | lld:pubmed |
| pubmed-article:17265480 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17265480 | pubmed:articleTitle | Fcgamma receptor type IIIA genotype and response to tumor necrosis factor alpha-blocking agents in patients with rheumatoid arthritis. | lld:pubmed |
| pubmed-article:17265480 | pubmed:affiliation | Linköping University, Linköping, Sweden. alfka@imk.liu.se | lld:pubmed |
| pubmed-article:17265480 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17265480 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:17265480 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| entrez-gene:2214 | entrezgene:pubmed | pubmed-article:17265480 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:17265480 | lld:entrezgene |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17265480 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17265480 | lld:pubmed |
